Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 27.1.2020 | EN | Official Journal of the European Union | C 27/68 |

---

Action brought on 27 November 2019 – Olimp Laboratories v EUIPO – OmniVision (Hydrovision)

(Case T-817/19)

(2020/C 27/68)

Language of the case: English

Parties

Applicant: Olimp Laboratories sp. z o.o. (Dębica, Poland) (represented by: M. Kondrat, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: OmniVision GmbH (Puchheim, Germany)

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant before the General Court

Trade mark at issue: Application for European Union figurative mark Hydrovision – Application for registration No 16 286 841

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 13 September 2019 in Case R 2371/2018-2

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision and refer the case back to the EUIPO for reconsideration; or |

|  |  |
| --- | --- |
| — | alter the contested decision; |

|  |  |
| --- | --- |
| — | award the costs in the Applicant’s favor. |

Pleas in law

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |

|  |  |
| --- | --- |
| — | Infringement of the principle of the protection of legitimate expectations and the principle of legal certainty. |

---

[Top](#document1)